drugset / Trial / NCT00162214
Study of Dasatinib in Patients With Advanced Solid Tumors
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of Segment 1 of the study is to determine the effect of ketoconazole on dasatinib. The purpose of Segment 2 is to learn how dasatinib affects tumor growth in patients with advanced solid tumors.
Timeline
- Start
- 2005-08
- Primary completion
- 2007-03
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketoconazole | Small molecule | 200 mg | Oral |
| Comparator | dasatinib anhydrous | Small molecule | 140 mg | Oral |